Match Document Document Title
US20140023707 Co-Processed Carbohydrate System as a Quick-Dissolve Matrix for Solid Dosage Forms  
The present invention comprises a co-processed carbohydrate system, and formulations produced therefrom, which formulations are directly compressible into solid dosage forms, some of which rapidly...
US20130243856 ORAL DRUG DELIVERY SYSTEM  
An oral drug delivery system comprising a coated tablet having one or more surfaces. The coated tablet further comprises a core and a coating surrounding the core. The core comprises an active...
US20150182467 TAMPER-RESISTANT ORAL OPIOID AGONIST FORMULATIONS  
Methods of decreasing abuse potentials of oral opioid dosage forms are described. In the methods, an opioid antagonist in a substantially non-releasable form is included in oral dosage forms...
US20110268797 MULTICOATED ALISKIREN FORMULATIONS  
An oral pharmaceutical formulation of aliskiren, or a pharmaceutically acceptable salt or polymorph thereof, having at least two coating layers.
US20110076326 MODIFIED PROTEIN EXCIPIENT FOR DELAYED-RELEASE TABLET  
The present invention relates to delayed release oral formulations comprising active ingredients and modified proteins used as excipients. The proteins have chemical modifications such as...
US20130095177 METHOD OF PREPARING AN ORAL DOSAGE FORM COMPRISING FINGOLIMOD  
The present invention relates to a method of preparing an intermediate containing fingolimod, a method of preparing granules containing fingolimod, a method of preparing an oral dosage form...
US20130059004 ORAL DRUG DELIVERY SYSTEM  
An oral drug delivery system comprising a coated tablet having one or more surfaces. The coated tablet further comprises a core and a coating surrounding the core. The core comprises an active...
US20110045068 PHARMACEUTICAL FORMULATIONS FOR THE ORAL ADMINISTRATION OF PPI  
The present invention relates to pharmaceutical formulations comprising a layer of compressed granules to facilitate the administration of oral PPI.
US20140023705 DOSAGE FORMS FOR ORAL ADMINISTRATION AND METHODS OF TREATMENT USING THE SAME  
The invention relates to dosage forms that provide prolonged therapy. In particular, the invention relates to dosage forms including various pluralities of drug-containing resin particles. The...
US20140079780 Crush resistant delayed-release dosage forms  
The invention relates to a dosage form comprising a physiologically effective amount of a physiologically active substance (A), a synthetic, semi-synthetic or natural polymer (C), optionally one...
US20110117193 ANTIRETROVIRAL DRUG FORMULATIONS FOR TREATMENT OF CHILDREN EXPOSED TO HIV/AIDS  
The present disclosure provides fast disintegrating formulations for the treatment of human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) in patients such as...
US20140314846 MULTIPLE UNIT PHARMACEUTICAL FORMULATION  
An orally disintegratable benzimidazole formulation, featuring a plurality of compressed pellets in a MUPS tablet. The individual units feature a substrate with the active ingredient and an...
US20100297226 MULTIPLE UNIT PHARMACEUTICAL FORMULATION  
An orally disintegratable benzimidazole formulation, featuring a plurality of compressed pellets in a MUPS tablet. The individual units feature a substrate with the active ingredient and an...
US20150056277 DRUG DELIVERY SYSTEM  
The invention relates to a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally...
US20150216992 EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE  
The present invention relates to extended release compositions of an amino-C2-C6-alkyl nitrate and of pharmaceutically acceptable salt thereof, in particular 2-aminoethyl nitrate, and to fixed...
US20140010874 Tamper Resistant Solid Oral Dosage Forms  
Disclosed in certain embodiments is a solid oral dosage form comprising: (a) an inert tamper resistant core; and (b) a coating surrounding the core, the coating comprising an active agent.
US20120251623 METHOD OF ADMINISTERING AN ACTIVE INGREDIENT USING A CHEWABLE ORAL DOSAGE FROM COMPRISING TEXTURE MASKED PARTICLES  
In one aspect, the present invention features a method of administering an active ingredient, said method comprising chewing an oral dosage form comprising a texture masked particle, said texture...
US20150196494 STABILIZED PICOPLATIN ORAL DOSAGE FORM  
The invention provides an oral dosage form for the anti-cancer drug picoplatin comprising a core and a coating, the dosage form being free of redox-active, metal salts. The core of the tablet is a...
US20100255091 ORAL FAST DISINTEGRATING TABLETS  
The present invention refers to an orally fast disintegrable pharmaceutically acceptable multiple units tablet dosage form comprising a) tablet excipients comprising a disintegrant and b)...
US20120189693 ORAL DOSAGE FORMS  
Aspects of the present invention are directed to oral dosage forms comprising a compressed microtablet, wherein said microtablet has a major dimension that is between about 0.25 mm and about 1.0...
US20130273157 ORALLY DISINTEGRATING TABLET  
A orally disintegrating tablet is obtained by tableting fine granules showing controlled release of lansoprazole and an additive, which is capable of suppressing breakage of the fine granules...
US20150140085 FORMULATIONS COMPRISING IBRUTINIB  
Oral pharmaceutical formulations of ibrutinib and/or a pharmaceutically acceptable salt thereof, methods for their administration, process of their production, and use of these formulations for...
US20130022678 ORAL CONTROLLED RELEASE DOSAGE FORM  
A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride.
US20110268799 ORAL CONTROLLED RELEASE DOSAGE FORM  
A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride.
US20130259936 LOW-DOSE DOXEPIN FORMULATIONS AND METHODS OF MAKING AND USING THE SAME  
The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
US20140287042 Oral Tablet Formulation Consisting Of Fixed Combination Of Rosuvastatin And Ezetimibe For Treatment Of Hyperlipidemia And Cardiovascular Diseases  
The present invention is an orally consumed fixed combination formulation of both rosuvastatin and ezetimibe in one tablet that is expected to have the same Area Under Curve as two active...
US20130122090 Multiple Unit Tablet Composition  
A multiple unit tablet composition comprising an enteric coated multiple unit cores comprising a pharmaceutically active ingredient, wherein plasticizer content of enteric coating is less than...
US20140242160 CALCIUM SUPPLEMENT  
An oral dosage form for administration to an animal comprising a biologically utilizable form of calcium and an extended release system that maintains the calcium level in the animal's bloodstream...
US20100330176 Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity  
The invention relates to the use of ambroxol and the pharmacologically acceptable salts thereof for preparing a pharmaceutical composition for the treatment of painful conditions in the oral and...
US20150250742 Dosage Forms Containing Terbutaline Sulphate  
A modified release oral dosage form comprising an internal phase containing terbutaline sulphate and a pharmaceutically acceptable excipient, dispersed in an external phase comprising...
US20110274751 TRIMETAZIDINE FORMULATION WITH DIFFERENT RELEASE PROFILES  
A multilayered solid oral pharmaceutical formulation of trimetazidine or a pharmaceutically acceptable salt or polymorph of trimetazidine wherein one layer of said formulation provides controlled...
US20140170216 BUPROPION HYDROBROMIDE POLYMORPHS  
Polymorphous and amorphous forms of bupropion hydrobromide are described.
US20130059005 BUPROPION HYDROBROMIDE POLYMORPHS  
Polymorphous and amorphous forms of bupropion hydrobromide are described.
US20150118303 Immediate Release Abuse-Deterrent Granulated Dosage Forms  
Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual...
US20150118302 Immediate Release Abuse-Deterrent Granulated Dosage Forms  
Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual...
US20140287039 Abiraterone Acetate Formulation  
Pharmaceutical compositions, including unit dosage forms, comprising fine particle abiraterone acetate with or without an antioxidant and or a sequestering agent as well as methods for producing...
US20140170215 ORALLY DISINTEGRATING TABLETS AND METHODS OF MANUFACTURE  
A tablet that rapidly disintegrates in the oral cavity comprising a compressed blend of rapidly dispersing microgranules prepared by granulating a sugar alcohol or a saccharide or a mixture...
US20140212488 ORAL TABLET FORMULATION CONSISTING OF IMMEDIATE RELEASE ROSUVASTATIN AND EXTENDED RELEASE METFORMIN  
A solid dosage product and formulation containing a fixed combination of rosuvastatin and metformin is provided here. In the formulation rosuvastatin is delivered immediately to the patient and...
US20130202698 L-ORNIDAZOLE FORMULATIONS AND THEIR APPLICATIONS IN TREATMENT OF PARASITIC INFECTIONS  
This invention relates to new methods of treating parasitic infections, such as trichomonas vaginalis infection and cecum amoeba infection, using L-enantiomer enriched ornidazole, in particular...
US20130273156 ORAL PHARMACEUTICAL TABLET FOR CONTROLLED RELEASE OF MESALAZINE AND PROCESS FOR OBTAINING IT  
The invention provides an oral pharmaceutical tablet for controlled release of mesalazine or a pharmaceutically acceptable salt thereof as active ingredient with a core and a gastro-resistant...
US20110104272 GASTRIC RETENTIVE EXTENDED-RELEASE DOSAGE FORMS COMPRISING COMBINATIONS OF ACETAMINOPHEN AND PHENYLEPHRINE  
Compositions and methods for the treatment of a mammal suffering from pain and from nasal congestion or ophthalmic disorders are described. More specifically, a dosage form designed for release of...
US20120064159 Multilayer Oral Tablets Containing a Non-Steroidal Anti-Inflammatory Drug and/or Acetaminophen  
Multilayer tablets of a non-steroidal anti-inflammatory drug (NSAID) and/or acetaminophen for oral administration containing an immediate release layer or layers containing a NSAID and/or...
US20110091546 COMPOSITION FOR RAPID DISINTEGRATING TABLET IN ORAL CAVITY  
The present invention provides rapid disintegrating tablets in oral cavity having a shortened disintegration time in oral cavity as well as a sufficient hardness with compared to rapid...
US20120294938 PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION WITH CONTROLLED ACTIVE INGREDIENT RELEASE IN THE SMALL INTESTINE AND METHOD FOR ITS PRODUCTION  
Any pharmaceutical preparation for oral administration with controlled release of active ingredient in the small bowel, on the basis of active ingredient carriers provided with at least one active...
US20140302137 FORMULATION FOR CO-THERAPY TREATMENT OF DIABETES  
The present invention is directed a pharmaceutical compositions for co-therapy treatment and prevention of glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X.
US20120009259 FORMULATION FOR CO-THERAPY TREATMENT OF DIABETES  
The present invention is directed a pharmaceutical compositions for co-therapy treatment and prevention of glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X.
US20150056275 CONTROLLED-RELEASE SOLID DOSAGE FORMS OF MESALAMINE  
Described are controlled-release solid dosage forms of mesalamine. In one aspect of the invention the controlled-release solid dosage forms of mesalamine are capsules comprising a plurality of...
US20130344146 DRY FORMULATIONS OF ARIPIPRAZOLE  
The invention encompasses dry compression pharmaceutical compositions of aripiprazole, methods of making tablets from the compositions, and tablets of the dry compression pharmaceutical composition.
US20140322321 TABLET CAPABLE OF COMBATTING MISUSE BY INJECTION  
The invention relates to an oral pharmaceutical composition in the form of a sustained-release tablet comprising an active ingredient capable of being misused, which composition makes it possible...
US20150037407 METHOD TO IMPROVE THE SAFETY OF HANDLING OF HIGH POTENCY DRUGS IN SOLID DOSAGE FORMS WITHOUT CHANGING THEIR EFFICACY  
A method to improve the safety of handling of drug substances that are dispensed as solid oral dosage forms is described that does not alter the drug-release profile and the therapeutic efficacy...